CATALANO, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 11.091
AS - Asia 1.322
EU - Europa 1.269
SA - Sud America 197
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 13.905
Nazione #
US - Stati Uniti d'America 11.050
SG - Singapore 608
CN - Cina 304
DE - Germania 286
IT - Italia 236
RU - Federazione Russa 174
BR - Brasile 164
UA - Ucraina 141
IE - Irlanda 115
VN - Vietnam 103
HK - Hong Kong 101
GB - Regno Unito 79
FR - Francia 66
FI - Finlandia 48
KR - Corea 44
BD - Bangladesh 39
JP - Giappone 32
SE - Svezia 25
NL - Olanda 24
IN - India 22
PL - Polonia 22
CA - Canada 18
BE - Belgio 14
ID - Indonesia 14
MX - Messico 13
AR - Argentina 11
ES - Italia 10
TR - Turchia 10
ZA - Sudafrica 10
IQ - Iraq 9
EC - Ecuador 8
GR - Grecia 6
PK - Pakistan 6
AT - Austria 4
CH - Svizzera 4
KZ - Kazakistan 4
LT - Lituania 4
PH - Filippine 4
UZ - Uzbekistan 4
CL - Cile 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
PE - Perù 3
RO - Romania 3
SA - Arabia Saudita 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
AZ - Azerbaigian 2
CO - Colombia 2
CR - Costa Rica 2
EU - Europa 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
PY - Paraguay 2
QA - Qatar 2
SV - El Salvador 2
TH - Thailandia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
GF - Guiana Francese 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
TZ - Tanzania 1
Totale 13.905
Città #
Woodbridge 3.204
Wilmington 2.704
Houston 2.473
Singapore 378
Fairfield 274
Ann Arbor 234
Ashburn 218
Chandler 206
San Jose 147
Seattle 134
Jacksonville 127
Beijing 104
Dublin 102
Cambridge 100
Hong Kong 100
New York 80
Rome 77
Medford 76
Santa Clara 67
Council Bluffs 66
Dearborn 61
Dallas 51
Zhengzhou 50
Los Angeles 40
Lawrence 36
Hanoi 31
Moscow 30
Buffalo 29
The Dalles 29
Ho Chi Minh City 27
Tokyo 24
Lauterbourg 23
San Diego 22
Colorado Springs 17
Menlo Park 17
Milan 17
Mülheim 17
Nuremberg 15
Helsinki 14
Orem 14
São Paulo 14
Brussels 13
Munich 13
Warsaw 13
Chennai 12
Jakarta 12
Shanghai 12
Phoenix 11
Chicago 10
London 10
Norwalk 9
Perugia 9
Boardman 8
Brooklyn 8
Nürnberg 8
Falls Church 7
Johannesburg 7
Mountain View 7
Oxford 7
Secaucus 7
Amsterdam 6
Belo Horizonte 6
Curitiba 6
Haiphong 6
Hefei 6
Mexico City 6
Poplar 6
Redondo Beach 6
University Park 6
Verona 6
Atlanta 5
Guangzhou 5
Kunming 5
Manchester 5
Montreal 5
Stockholm 5
Biên Hòa 4
Brescia 4
Columbus 4
Frankfurt am Main 4
Istanbul 4
La Veta 4
Nanchang 4
Paris 4
Pisa 4
Querétaro 4
Redwood City 4
Seoul 4
Athens 3
Baghdad 3
Benxi 3
Bắc Ninh 3
Calgary 3
Charlotte 3
Creede 3
Denver 3
Dong Ket 3
Florence 3
Kingston 3
Kraków 3
Totale 11.806
Nome #
A microgranular variant of acute promyelocytic leukemia with atypical morpho-cytochemical features and an early myeloid immunophenotype 533
A case of SRSF2 mutation in chronic lymphocytic leukemia 518
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation 498
Identification of a potential topoisomerase II “hotspot” DNA region in the DEK gene in two t(6;9)-positive therapy-related myeloid neoplasms 472
Development of a High-Resolution Melting Curve Analysis Screening Test for SRSF2 Splicing Factor Gene Mutations in Myelodysplastic Syndromes 469
PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity 458
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A new class of agents with high apoptotic activity in chronic myelogenous leukemia K562 cells and in cells from patients at onset and who were imatinib-resistant 450
Imatinib-mesylate for all patients with hypereosinophilic syndrome? 446
Induction of Apoptosis by Pyrrolobenzothiadiazepines (PBTDs) in cell lines and in 12 chronic myeloid leukaemia patients and imatinib-resistant 444
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A New Class of Agents with High Apoptotic Activity in Chronic Myelogenous Leukemia K562 Cells and in Cells from Patients at Onset and Who Were Imatinib-Resistant. 438
Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patients 435
Expression cDNA cloning of a novel oncogene with sequence similarity to regulators of small GTP-binding proteins 427
High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro 427
Complex and multifaceted therapy-related myeloid neoplasm following laryngeal cancer treated with Cisplatin and radiotherapy 426
Benzodiazepine derivatives and uses thereof in medical field 424
PYRROLO[1,2-b][1,2,5]BENZOTHIADIAZEPINES (PBTDs) induce apoptosis in K562 cells. 409
“Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs) induce apoptosis in primari chronic myelogenous leukemic cells”. 400
Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursors 398
Induction of Apoptosis by Pyrrolobenzothiadiazepines (PBTDs) in cell lines and in 12 chronic myeloid leukaemia patients and imatinib-resistant 396
Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis 392
Positive selection of CD34+ cells by immunoadsorption: factors affecting the final yield and hematopoietic recovery in patients with hematological malignancies and solid tumors 387
null 385
Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia 381
Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy 376
PML/RARA inhibits expression of HSP90 and its target AKT 366
Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. 357
Sarcoma di Kaposi e neoplasie linfoproliferative 344
Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia 343
[Current aspects of treatment of multiple myeloma] 342
Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies 272
PML/RARa interferes with NRF2 transcriptional activity increasing the sensitivity to ascorbate of acute promyelocytic leukemia cells 244
Absence of FGFR3-TACC3 rearrangement in hematological malignancies with numerical chromosomal alteration 181
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients 133
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment 124
Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation. 113
NPM1 mutated, BCR-ABL1 positive myeloid neoplasms: review of the literature 113
Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia. 100
PLZF-RARΑ ENHANCES METABOLIC PLASTICITY AND ROS SCAVENGING IN AML CELLS 99
Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies 88
PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias 73
Venetoclax and new BCL-2 inhibitors in acute myeloid leukemia 62
Molecular Targets of Oxidative Stress: Focus on Nuclear Factor Erythroid 2–Related Factor 2 Function in Leukemia and Other Cancers 51
Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes 50
Correction: Niscola et al. Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies. Curr. Oncol. 2024, 31, 6632–6658 44
The Management of Membranous Glomerulopathy in Allogeneic Stem Cells Transplantation: Updated Literature 41
Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes 38
Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications 35
Totale 14.002
Categoria #
all - tutte 32.049
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.049


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 0 0 0 0 0 16
2021/2022370 15 55 8 25 11 24 26 13 22 25 24 122
2022/2023513 53 46 25 49 50 111 39 24 57 13 28 18
2023/2024202 29 7 17 8 25 65 3 1 3 5 6 33
2024/2025870 18 243 100 66 29 51 72 33 105 47 57 49
2025/20261.886 141 71 208 159 185 77 278 195 203 202 84 83
Totale 14.002